Search

everythinglearnresearchcommunity

for

Search:↓

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

Some drugs used to treat immune conditions may cause different types of hair loss.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Etanercept, a psoriasis treatment, caused hair loss in a patient.

Adalimumab can cause complete hair loss in rare cases.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Hair loss requires customized treatments based on its various causes and types.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

Ustekinumab might work for severe psoriasis, but more research is needed to be sure.

New acne treatments include combination creams, advanced retinoids, and light therapies, focusing on safety and patient adherence.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

More research is needed to find the best treatment for dissecting cellulitis of the scalp.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

Some drugs may increase the risk of obstructive sleep apnea, while others like certain biologics might decrease it.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

Lupus can cause different skin problems, and treatments like quitting smoking and using certain creams or medicines can help.

Infliximab may cause hair loss in Crohn's disease patients.

Cornification is how skin cells die to form the protective outer layer of skin, hair, and nails.

Different types of cell death affect skin health and inflammation, and understanding them could improve treatments for skin diseases.

PPARγ is essential for maintaining healthy skin, controlling inflammation, and ensuring proper skin barrier function.

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

Some treatments like topical oxygen and stem cells show promise for wound healing and hair growth, but evidence for modern dressings over traditional ones is limited.